Titlebook: Novel Developments in Stem Cell Mobilization; Focus on CXCR4 Stefan Fruehauf,W. Jens Zeller,Gary Calandra Book 2012 Springer Science+Busine

只看該作者 · 發(fā)表于 2025-3-23 10:44:20

Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hem

只看該作者 · 發(fā)表于 2025-3-23 16:31:23

只看該作者 · 發(fā)表于 2025-3-23 18:55:28

Book 2012hich are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented.

只看該作者 · 發(fā)表于 2025-3-23 23:16:41

Maximilian M. Fresen,Kai Hübelon and the role of industry. Chapter 4 discusses recent developments, including the impact on green jobs and green funds, and Chapter 5 reflects on the policies that have been proposed and their potential implications.978-3-319-25508-8978-3-319-25510-1Series ISSN 2191-5520 Series E-ISSN 2191-5539

只看該作者 · 發(fā)表于 2025-3-24 04:20:49

只看該作者 · 發(fā)表于 2025-3-24 08:55:01

只看該作者 · 發(fā)表于 2025-3-24 10:56:15

只看該作者 · 發(fā)表于 2025-3-24 17:10:34

只看該作者 · 發(fā)表于 2025-3-24 22:51:57

. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented.978-1-4899-9376-2978-1-4614-1960-0

只看該作者 · 發(fā)表于 2025-3-25 00:03:41

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 15:43
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved